- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
Détention brevets de la classe C12N 15/85
Brevets de cette classe: 12142
Historique des publications depuis 10 ans
|
630
|
766
|
1016
|
1020
|
897
|
1020
|
1053
|
1163
|
1106
|
869
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4822 |
407 |
| The Regents of the University of California | 20924 |
229 |
| Massachusetts Institute of Technology | 10313 |
165 |
| The Trustees of the University of Pennsylvania | 4441 |
149 |
| President and Fellows of Harvard College | 6118 |
143 |
| The Board of Trustees of the Leland Stanford Junior University | 6722 |
113 |
| The Broad Institute, Inc. | 1992 |
105 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 239 |
68 |
| Sangamo Therapeutics, Inc. | 383 |
64 |
| Kymab Limited | 281 |
63 |
| The Johns Hopkins University | 5948 |
62 |
| Duke University | 3191 |
62 |
| The General Hospital Corporation | 4895 |
60 |
| Board of Regents, The University of Texas System | 6177 |
57 |
| Modernatx, Inc. | 1279 |
52 |
| University of Massachusetts | 2337 |
52 |
| Yale University | 2573 |
52 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3019 |
50 |
| Novartis AG | 10172 |
47 |
| The Board of Regents of the University of Texas System | 2312 |
45 |
| Autres propriétaires | 10097 |